# Dynavax Technologies Corporation (DVAX)

Source: https://www.quantisnow.com/company/DVAX
Generated: 2026-11-21T06:56:00.363Z

- Ticker: DVAX
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- IPO year: 2004
- Website: dynavax.com

## About

Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufactures and sells CpG 1018, the adjuvant used in HEPLISAV-B. Dynavax Technologies Corporation has a collaboration agreement with Valneva Scotland Limited; agreement with Serum Institute of India Pvt. Ltd.; and sublicense agreement with Merck, Sharp & Dohme Corp. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. Dynavax Technologies Corporation was incorporated in 1996 and is headquartered in Emeryville, California.

## Latest DVAX news and filings

- 2026-02-20 11:05 UTC [SEC Form 15-12G filed by Dynavax Technologies Corporation](https://www.quantisnow.com/insight/sec-form-15-12g-filed-by-dynavax-technologies-corporation-6403868)
- 2026-02-17 05:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Dynavax Technologies Corporation](https://www.quantisnow.com/insight/sec-form-effect-filed-by-dynavax-technologies-corporation-6393931)
- 2026-02-11 21:30 UTC [SEC Form 4] [SEC Form 4 filed by Large owner Deep Track Biotechnology Master Fund, Ltd.](https://www.quantisnow.com/insight/sec-form-4-filed-by-large-owner-deep-track-biotechnology-6386969)
- 2026-02-10 21:26 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Dynavax Technologies Corporation](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-dynavax-technologies-corporation-6384402)
- 2026-02-10 21:25 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Dynavax Technologies Corporation](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-dynavax-technologies-corporation-6384392)
- 2026-02-10 21:24 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Dynavax Technologies Corporation](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-dynavax-technologies-corporation-6384380)
- 2026-02-10 21:23 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Dynavax Technologies Corporation](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-dynavax-technologies-corporation-6384375)
- 2026-02-10 21:22 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Dynavax Technologies Corporation](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-dynavax-technologies-corporation-6384361)
- 2026-02-10 21:21 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Dynavax Technologies Corporation](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-dynavax-technologies-corporation-6384352)
- 2026-02-10 21:19 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Dynavax Technologies Corporation](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-dynavax-technologies-corporation-6384330)
- 2026-02-10 21:18 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Dynavax Technologies Corporation](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-dynavax-technologies-corporation-6384316)
- 2026-02-10 21:16 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Dynavax Technologies Corporation](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-dynavax-technologies-corporation-6384293)
- 2026-02-10 21:15 UTC [SEC Form 4] [Director Emini Emilio returned 10,075 units of Common Stock - Restricted Stock Units to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/director-emini-emilio-returned-10075-units-of-common-stock---6384275)
- 2026-02-10 21:15 UTC [SEC Form 4] [Director Myers Scott Dunseth returned 31,204 units of Common Stock - Restricted Stock Units to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/director-myers-scott-dunseth-returned-31204-units-of-common-stock-6384267)
- 2026-02-10 21:15 UTC [SEC Form 4] [VP, Chief Accounting Officer Metzinger Joseph Anthony closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/vp-chief-accounting-officer-metzinger-joseph-anthony-closing-all-direct-6384257)
- 2026-02-10 21:15 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Dynavax Technologies Corporation](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-dynavax-technologies-corporation-6384256)
- 2026-02-10 21:15 UTC [SEC Form 4] [Director Kisner Daniel L returned 21,829 units of Common Stock - Restricted Stock Units to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/director-kisner-daniel-l-returned-21829-units-of-common-stock-6384249)
- 2026-02-10 21:15 UTC [SEC Form 4] [SVP and CFO Macdonald Kelly was granted 88,854 units of Common Stock - Performance Stock Units and returned 88,854 units of Common Stock - Performance Stock Units to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/svp-and-cfo-macdonald-kelly-was-granted-88854-units-of-6384247)
- 2026-02-10 21:15 UTC [SEC Form 4] [Director Sun Elaine D returned 29,865 units of Common Stock - Restricted Stock Units to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/director-sun-elaine-d-returned-29865-units-of-common-stock-6384246)
- 2026-02-10 21:15 UTC [SEC Form 4] [CEO and Director Spencer Ryan was granted 301,000 units of Common Stock - Performance Stock Units and returned 301,000 units of Common Stock - Performance Stock Units to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/ceo-and-director-spencer-ryan-was-granted-301000-units-of-6384245)
- 2026-02-10 21:15 UTC [SEC Form 4] [SVP General Counsel Slebir John L was granted 92,424 units of Common Stock - Performance Stock Units and returned 92,424 units of Common Stock - Performance Stock Units to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/svp-general-counsel-slebir-john-l-was-granted-92424-units-6384244)
- 2026-02-10 21:14 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Dynavax Technologies Corporation](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-dynavax-technologies-corporation-6384239)
- 2026-02-10 21:15 UTC [SEC Form 4] [Director Silvernail Lauren P returned 10,075 units of Common Stock - Restricted Stock Units to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/director-silvernail-lauren-p-returned-10075-units-of-common-stock-6384236)
- 2026-02-10 21:15 UTC [SEC Form 4] [Director Cano Francis returned 42,663 units of Common Stock - Restricted Stock Units to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/director-cano-francis-returned-42663-units-of-common-stock---6384235)
- 2026-02-10 21:15 UTC [SEC Form 4] [Director Macgregor Brent returned 21,829 units of Common Stock - Restricted Stock Units to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/director-macgregor-brent-returned-21829-units-of-common-stock---6384234)
- 2026-02-10 21:15 UTC [SEC Form 4] [President & COO Novack David F was granted 124,224 units of Common Stock - Performance Stock Units and returned 124,224 units of Common Stock - Performance Stock Units to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/president-coo-novack-david-f-was-granted-124224-units-of-6384228)
- 2026-02-10 21:13 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Dynavax Technologies Corporation](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-dynavax-technologies-corporation-6384185)
- 2026-02-10 21:12 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Dynavax Technologies Corporation](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-dynavax-technologies-corporation-6384176)
- 2026-02-10 21:10 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Dynavax Technologies Corporation](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-dynavax-technologies-corporation-6384148)
- 2026-02-10 21:09 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Dynavax Technologies Corporation](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-dynavax-technologies-corporation-6384140)
- 2026-02-10 21:08 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Dynavax Technologies Corporation](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-dynavax-technologies-corporation-6384107)
- 2026-02-10 21:06 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Dynavax Technologies Corporation](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-dynavax-technologies-corporation-6384078)
- 2026-02-10 21:07 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Dynavax Technologies Corporation](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-dynavax-technologies-corporation-6384062)
- 2026-02-10 21:04 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Dynavax Technologies Corporation](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-dynavax-technologies-corporation-6384001)
- 2026-02-10 21:03 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Dynavax Technologies Corporation](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-dynavax-technologies-corporation-6383938)
- 2026-02-10 21:01 UTC [SEC Form POS AM filed by Dynavax Technologies Corporation](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-dynavax-technologies-corporation-6383915)
- 2026-02-10 14:10 UTC [SEC Form 8-K] [Dynavax Technologies Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Leadership Update](https://www.quantisnow.com/insight/dynavax-technologies-corporation-filed-sec-form-8-k-entry-into-a-6383366)
- 2026-02-10 11:36 UTC [SEC Schedule 14D-9] [Amendment: SEC Form SC 14D9/A filed by Dynavax Technologies Corporation](https://www.quantisnow.com/insight/amendment-sec-form-sc-14d9a-filed-by-dynavax-technologies-corporation-6382882)
- 2026-02-04 23:15 UTC [Leadership Update] [Ciena Set to Join S&P 500; Arrowhead Pharmaceuticals to Join S&P MidCap 400; ADT and OneSpaWorld Holdings to Join S&P SmallCap 600](https://www.quantisnow.com/insight/ciena-set-to-join-sp-500-arrowhead-pharmaceuticals-to-join-6376037)
- 2026-02-02 11:30 UTC [SEC Schedule 14D-9] [Amendment: SEC Form SC 14D9/A filed by Dynavax Technologies Corporation](https://www.quantisnow.com/insight/amendment-sec-form-sc-14d9a-filed-by-dynavax-technologies-corporation-6368784)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/DVAX
- Earnings history: https://www.quantisnow.com/earnings/DVAX
- Dividend history: https://www.quantisnow.com/dividends/DVAX
- Insider transactions: https://www.quantisnow.com/insiders/DVAX
- Options chain: https://www.quantisnow.com/options/DVAX
- SEC 8-K filings only: https://www.quantisnow.com/company/DVAX/8-k
- RSS and alerts for DVAX: https://www.quantisnow.com/docs/rss-feeds.md
